Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$4.23
+9.3%
$5.72
$2.90
$11.16
$313.88M0.473.27 million shs11.52 million shs
American Tower Corporation stock logo
AMT
American Tower
$224.62
+1.6%
$215.82
$172.51
$243.56
$103.47B0.822.50 million shs2.57 million shs
QCC
Quadron Cannatech
$0.27
$0.16
$0.77
N/AN/A32,330 shsN/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
+9.30%-41.17%-22.10%-11.51%-41.25%
American Tower Corporation stock logo
AMT
American Tower
+1.66%+0.24%+4.58%+3.17%+15.75%
QCC
Quadron Cannatech
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
2.2959 of 5 stars
3.51.00.00.02.91.70.6
American Tower Corporation stock logo
AMT
American Tower
3.8696 of 5 stars
2.63.01.73.13.61.70.0
QCC
Quadron Cannatech
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
3.00
Buy$19.00349.17% Upside
American Tower Corporation stock logo
AMT
American Tower
3.11
Buy$240.256.96% Upside
QCC
Quadron Cannatech
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest QCC, ADR, AMT, and ALT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/27/2025
Altimmune, Inc. stock logo
ALT
Altimmune
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
6/27/2025
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
5/19/2025
American Tower Corporation stock logo
AMT
American Tower
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$255.00
5/1/2025
American Tower Corporation stock logo
AMT
American Tower
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$240.00 ➝ $250.00
4/30/2025
American Tower Corporation stock logo
AMT
American Tower
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$230.00 ➝ $240.00
4/30/2025
American Tower Corporation stock logo
AMT
American Tower
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$234.00 ➝ $248.00
4/30/2025
American Tower Corporation stock logo
AMT
American Tower
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$248.00 ➝ $260.00
4/30/2025
American Tower Corporation stock logo
AMT
American Tower
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetStrong-Buy ➝ Strong-Buy$231.00 ➝ $251.00
4/30/2025
American Tower Corporation stock logo
AMT
American Tower
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$245.00 ➝ $250.00
4/22/2025
American Tower Corporation stock logo
AMT
American Tower
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
4/22/2025
American Tower Corporation stock logo
AMT
American Tower
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$220.00 ➝ $234.00
(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$20K17,154.77N/AN/A$1.74 per share2.43
American Tower Corporation stock logo
AMT
American Tower
$10.13B10.38$11.77 per share19.09$20.64 per share10.88
QCC
Quadron Cannatech
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$95.06M-$1.26N/AN/AN/A-451,200.00%-65.44%-58.43%8/6/2025 (Estimated)
American Tower Corporation stock logo
AMT
American Tower
$2.26B$3.8957.7422.461.6417.34%30.20%4.82%7/29/2025 (Estimated)
QCC
Quadron Cannatech
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest QCC, ADR, AMT, and ALT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2025Q2 2025
American Tower Corporation stock logo
AMT
American Tower
$2.59N/AN/AN/A$2.58 billionN/A
5/13/2025Q1 2025
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.35-$0.26+$0.09-$0.26$0.00 million$0.01 million
4/29/2025Q1 2025
American Tower Corporation stock logo
AMT
American Tower
$2.41$2.75+$0.34$2.75$2.54 billion$2.56 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
American Tower Corporation stock logo
AMT
American Tower
$6.803.03%N/A174.81%1 Years
QCC
Quadron Cannatech
N/AN/AN/AN/AN/A

Latest QCC, ADR, AMT, and ALT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2025
American Tower Corporation stock logo
AMT
American Tower
quarterly$1.703.21%6/13/20256/13/20257/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
15.85
15.85
American Tower Corporation stock logo
AMT
American Tower
3.43
0.81
0.81
QCC
Quadron Cannatech
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
78.05%
American Tower Corporation stock logo
AMT
American Tower
92.69%
QCC
Quadron Cannatech
N/A

Insider Ownership

CompanyInsider Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
4.10%
American Tower Corporation stock logo
AMT
American Tower
0.18%
QCC
Quadron Cannatech
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5081.11 million77.78 millionOptionable
American Tower Corporation stock logo
AMT
American Tower
4,691468.14 million467.30 millionOptionable
QCC
Quadron Cannatech
N/AN/AN/ANot Optionable

Recent News About These Companies

Hemp Gummies vs. CBD Gummies: 5 Products to Try in 2024
Qassim Cement Co
Attleboro grants first recreational pot shop permit

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Altimmune stock logo

Altimmune NASDAQ:ALT

$4.23 +0.36 (+9.30%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$4.16 -0.07 (-1.54%)
As of 07/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

American Tower stock logo

American Tower NYSE:AMT

$224.62 +3.60 (+1.63%)
Closing price 07/1/2025 03:59 PM Eastern
Extended Trading
$224.02 -0.60 (-0.27%)
As of 07/1/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.

Quadron Cannatech CNSX:QCC

Quadron Cannatech Corporation, an automated extraction and processing solutions company, provides ancillary equipment, products, and services for authorized cannabis industry participants in Canada. The company offers design and manufacturing extraction, processing, and production equipment for lease/sale; and packages and sells consumption and dispensing hardware and supplies. It also involved in the laboratory analytics, organic compound extraction, distillation, purification, and formulation development activities; and research and development activities in the areas of engineering, process automation, manufacturing, development of standards and IP related to extraction, processing and refinement, advanced cannabis chemistry, product development, analytical testing, best practices, and others. In addition, the company offers extract and product development consultation services, custom ancillary solutions, branded consumption devices, and packaging services, as well as vapor pens for medical and recreational consumers. Further, it provides process technical services; automation systems; standard and custom machines; VFD/drive and robotic-XY systems; and turnkey solutions, including shop and field machine based services, custom machining, and field repairs. Additionally, the company designs and supplies heat transfer systems, such as cooling systems, chillers, resin systems, melters, process heat systems, reverse osmosis systems, and cooling towers; designs and repairs custom electronics and communications interfaces; and supplies control packages. The company was formerly known as Quadron Capital Corporation and changed its name to Quadron Cannatech Corporation in May 2017. Quadron Cannatech Corporation was incorporated in 2011 and is headquartered in Vancouver, Canada.